Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients.
Pakkala
S
S
Finnish Red Cross Blood, Helsinki, Finland.
Salmela
K
K
Lautenschlager
I
I
Ahonen
J
J
Häyry
P
P
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000517:prevention & control*
D000961:Antilymphocyte Serum